PharmaCyte Biotech Announces Uplist to The Nasdaq Capital Market and Launch of Public Offering

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–$NASDAQ #bigboardstock–PharmaCyte Biotech, Inc. (OTCQB: PMCBD) (PharmaCyte or Company), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that The Nasdaq Stock Market LLC (Nasdaq) has approved the listing of the Company’s common stock on Nasdaq. The Company’s common stock … [Read more…]

LivaNova Announces Offering of Ordinary Shares

LONDON–(BUSINESS WIRE)–#cardiovascular–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has commenced an underwritten offering of $300 million of its ordinary shares. LivaNova also intends to grant the underwriters of the offering a 30-day option to acquire up to an additional 15% of the ordinary shares offered on the same terms … [Read more…]

Adamas to Announce Second Quarter Financial Results and Host Conference Call on August 9, 2021

EMERYVILLE, Calif.–(BUSINESS WIRE)–Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report second quarter 2021 financial results on Monday, August 9, after market close. Subsequently, Adamas’ management team will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the financial results and provide a corporate update. Investor Conference Call … [Read more…]

Vaccinate or Get Tested: Federal & State Governments, CDC, Corporations Issue New Directives as Delta Variant Fuels Demand for Recuro COVID At-Home or Onsite Testing Platform

DALLAS–(BUSINESS WIRE)–#athomecovidtesting—Recuro Health (Recuro), an integrated digital health solution that evolves healthcare from a reactive, disease-focused model to a personalized, proactive system, reports sharp, increased employer demand for at-home or on site COVID testing to ensure a safe return-to-work and participation at crucial meetings, events and conventions. Amid the surge of the Delta variant, recurrence … [Read more…]

Advanced Clinical’s Graham Belgrave Named to the 2021 PharmaVOICE 100 List of Distinguished Leaders

DEERFIELD, Ill.–(BUSINESS WIRE)–Graham Belgrave, Senior Vice President of European Operations at Advanced Clinical, has been recognized by PharmaVOICE magazine as a distinguished leader on the 2021 PharmaVOICE 100 list. As one of the first European hires at Advanced Clinical in 2017, Graham Belgrave built the company’s infrastructure and functional teams outside of North America, contributing … [Read more…]

DKT International and Embassy of the Kingdom of the Netherlands in Uganda Commit to Increase Access to Sexual and Reproductive Health Commodities and Services

With critical support from the Netherlands, DKT will address roadblocks to accessibility of contraception and reproductive health services via social marketing WASHINGTON–(BUSINESS WIRE)–DKT International, one of the largest providers of contraception and family planning products and services in low-and middle-income countries, has just signed a $5.9 million agreement with the Embassy of the Kingdom of … [Read more…]

CORRECTING and REPLACING PAVmed to Hold Business Update Conference Call on August 12, 2021

Company conference call and webcast at EDT 4:30PM EDT NEW YORK–(BUSINESS WIRE)–$pavm #earnings–First paragraph, first sentence of release should read: …Thursday, August 12, 2021, at 4:30 PM EDT (instead of Monday, August 12, 2021, at 4:30 PM EDT). The updated release reads: PAVMED TO HOLD BUSINESS UPDATE CONFERENCE CALL ON AUGUST 12, 2021 PAVmed Inc. … [Read more…]

NAMSA Acquires Leading Clinical Research Organization Clinlogix to Enhance Therapeutic Expertise and Global Footprint

TOLEDO, Ohio & PHILADELPHIA–(BUSINESS WIRE)–#CRO—NAMSA, the world’s only 100% medical device-focused Contract Research Organization (CRO) providing full continuum development solutions, announced today its acquisition of Clinlogix, a leading, Philadelphia-based global clinical research organization. Third in an advancing series, this acquisition follows NAMSA’s purchase announcements of Syntactx and American Preclinical Services (APS) in early 2021. Clinlogix, … [Read more…]

The Siegel Group Launches New COVID-19 Vaccination Incentive Programs

LAS VEGAS–(BUSINESS WIRE)–The Siegel Group, who introduced the “Live Here Eat Free” program during the Great Recession as featured in the New York Times, and reinstated the program at the outset of the COVID-19 Pandemic, announced today that it is rolling out two new nation-wide vaccination incentive programs: 1) a customer incentive program and 2) … [Read more…]

Lightbeam Health Solutions Partners with Surescripts to Promote Medication Adherence Across Populations

Integration with Surescripts provides Lightbeam clients with patient prescription history and real-time refill notifications IRVING, Texas–(BUSINESS WIRE)–#ACO–Lightbeam Health Solutions, the leader in end-to-end population health management solutions and services, announces a new partnership with Surescripts, a nationwide health information network. The Surescripts Medication History for Populations service will be available to Lightbeam clients through the … [Read more…]